anaphylaxis; hives; rash; swelling; vomiting; chest and joint pain; chest and joint pain; chronic cough; difficulty breathing; high blood pressure; dizzyness; difficulty sleeping; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32-year-old male patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) at the age of 32 years for covid-19 immunisation. The patient's relevant medical history included: "pelvic surgery (2010)", start date: 2010 (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, lot unknown), for COVID-19 immunization. The following information was reported: ANAPHYLACTIC REACTION (medically significant) with onset 17Apr2022 at 12:00, outcome "not recovered", described as "anaphylaxis"; CHEST PAIN (non-serious), ARTHRALGIA (non-serious) all with onset 17Apr2022 at 12:00, outcome "not recovered" and all described as "chest and joint pain"; COUGH (non-serious) with onset 17Apr2022 at 12:00, outcome "not recovered", described as "chronic cough"; DYSPNOEA (non-serious) with onset 17Apr2022 at 12:00, outcome "not recovered", described as "difficulty breathing"; INSOMNIA (non-serious) with onset 17Apr2022 at 12:00, outcome "not recovered", described as "difficulty sleeping"; DIZZINESS (non-serious) with onset 17Apr2022 at 12:00, outcome "not recovered", described as "dizzyness"; HYPERTENSION (non-serious) with onset 17Apr2022 at 12:00, outcome "not recovered", described as "high blood pressure"; URTICARIA (non-serious) with onset 17Apr2022 at 12:00, outcome "not recovered", described as "hives"; RASH (non-serious) with onset 17Apr2022 at 12:00, outcome "not recovered"; SWELLING (non-serious) with onset 17Apr2022 at 12:00, outcome "not recovered"; VOMITING (non-serious) with onset 17Apr2022 at 12:00, outcome "not recovered". The events "anaphylaxis", "hives", "rash", "swelling", "vomiting", "chest and joint pain", "chronic cough", "difficulty breathing", "high blood pressure", "dizzyness" and "difficulty sleeping" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: Blood pressure measurement: (17Apr2022) High. Therapeutic measures were taken as a result of anaphylactic reaction, urticaria, rash, swelling, vomiting, chest pain, arthralgia, cough, dyspnoea, hypertension, dizziness, insomnia.   Clinical course included the adverse event occurred well after giving received the vaccine so he cannot say that it was responsible for certain.symptoms started nearly two months ago (4/20-6/15) and include: hives/rash, swelling, vomiting, chest and joint pain, chronic cough, difficulty breathing, high blood pressure, dizziness, and anaphylaxis. these persist despite the use of antihistamines which help to somewhat blunt the severity of the reaction. Without use of an antihistamine, the rash covers the entirety of his body, is accompanied by joint and chest pain, together with swelling, a strong cough, and vomiting, amongst the other symptoms listed. With treatment the symptoms are mostly limited to a mild rash, with difficulty sleeping and a cough. no other vaccine in four weeks and other medication taken in 2 weeks. AE treatment included antihistamines and steroid crean. no known allergies.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.